- PLN1.57bn
- PLN1.00bn
- $283.44m
- 100
- 84
- 56
- 95
2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | — | — | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 259 | 333 | 374 | 319 | 283 |
Cost of Revenue | |||||
Gross Profit | 180 | 233 | 262 | 222 | 201 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 245 | 283 | 329 | 280 | 189 |
Operating Profit | 14.2 | 50.2 | 44.6 | 38.6 | 94.1 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 8.85 | -76.2 | -1 | 39.1 | 98.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4.27 | -82.6 | -9.68 | 32 | 82.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 4.27 | -82.6 | -9.68 | 32 | 82.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 4.27 | -82.6 | -9.68 | 32 | 82.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.051 | -0.981 | -0.117 | 0.664 | 1.15 |